Clinical Trial Update: Safety and Efficacy of Corneal Crosslinking Using the PXL-Platinum 330 for Eyes With Corneal Ectatic Conditions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating corneal crosslinking with PXL-Platinum 330 for keratoconus and cornea ectasia was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cornea Ectasia
• Keratoconus

Drugs mentioned

• PXL-Platinum 330

Snippet

Sponsor: Arbor Center for Eye Care | Conditions: Keratoconus, Cornea Ectasia | Phase 2 | Status: TERMINATED | Results posted: 2024-09-23